Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
Optimi Health Corp. announces it has secured naturally derived ibogaine supply from two sources and will begin finished drug product development at its Canadian GMP facility. This progress follows a recent U.S. executive order prioritizing ibogaine for accelerated FDA review and expanded patient access. The company is developing encapsulated dosage…